Alice Hall-Partyka
Areas of Focus
Overview
Alice Hall-Partyka counsels payers, providers, and technology companies on a broad range of health care regulatory, corporate, and policy matters. Alice uses her industry experience to help clients identify practical solutions and navigate complex regulatory frameworks.
Career & Education
- University of Southern California, B.A., summa cum laude, Phi Beta Kappa, Environmental Studies, 2014
- University of Southern California, B.S., summa cum laude, Phi Beta Kappa, Global Health, 2014
- Stanford Law School, J.D., High Pro Bono Distinction, 2017
- California
Alice's Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 5 min read | 03.06.26
Tri-Agencies Release Fourth Mental Health Parity Report to Congress
Blog Post | 03.04.26
Let’s Talk FCA: Gender-Affirming Care and Anti-DEI Executive Orders
Podcast | 03.02.26
Let’s Talk FCA: Gender-Affirming Care and Anti-DEI Executive Orders
Recognition
- Inland Counties Legal Services: Volunteer of the Year, 2022
Alice's Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 5 min read | 03.06.26
Tri-Agencies Release Fourth Mental Health Parity Report to Congress
Blog Post | 03.04.26
Let’s Talk FCA: Gender-Affirming Care and Anti-DEI Executive Orders
Podcast | 03.02.26
Let’s Talk FCA: Gender-Affirming Care and Anti-DEI Executive Orders
Insights
Tri-Agencies Finalize NQTL Comparative Analysis Standards In Final Rule
|12.23.24
Employee Benefit Plan Review
- |
05.16.24
Daily Journal (subscription required)
Is There a Right to Health in the U.S.?
|09.01.22
Laws of Medicine: Core Legal Aspects for the Healthcare Professional
Balancing The New Interoperability Rules With Existing Privacy Laws: Challenges for Payers
|10.01.20
AHLA Health Law Connection
Texas v. U.S.: Potential Impacts on Health Care Innovation and Fraud and Abuse Prevention
|11.18.19
AHLA News and Analysis
Your Next Cybersecurity Breach Will Be Your 401(k)...Soon
|07.01.18
Westlaw's Journal of Compensation and Benefits
ACOs and Antitrust: What Ever Became of the FTC?
|04.01.18
AHLA Connections
HHS Final Rule Revising ACA Section 1557 Nondiscrimination Regulations: Significant Impact on Healthcare Providers
|08.06.24
More States Increasing Scrutiny Of Healthcare Transactions, With Skilled Nursing Targeted
|08.15.23
McKnight's Long-Term Care News
Let’s Talk FCA: Gender-Affirming Care and Anti-DEI Executive Orders
|03.04.26
Crowell & Moring’s Government Contracts Legal Forum
Legal Challenges to the One Big Beautiful Bill Act’s Restrictions on Federal Medicaid Funding
|08.12.25
Crowell & Moring's Health Law Blog
- |
07.08.25
Crowell & Moring’s State AG Blog
- |
07.18.24
Crowell & Moring's Health Law Blog HHS Aims to Strengthen Anti-Discrimination Rules for Disabled Patients in New Proposed Rule
|10.18.23
Crowell & Moring’s Health Law Blog
Required Coverage of COVID-19 Testing for Essential Workers in California
|07.29.20
Crowell & Moring's Health Law Blog
CMS & State Medicaid Agencies Seek to Expand Enrollee Protections During COVID-19 Pandemic
|03.23.20
Crowell & Moring's Health Law Blog
Practices
- Health Care
- Corporate and Transactional
- Managed Care
- Government Health Care Programs
- Health Care Policy and Government Affairs
- Investigations
- Government Affairs
- Commercial Contracts and Outsourcing
- Corporate Counseling, Governance and Compliance
- Health Care Fraud and Abuse
- Digital Health and Health Information Technology
- Hospital Systems and Providers
Alice's Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 5 min read | 03.06.26
Tri-Agencies Release Fourth Mental Health Parity Report to Congress
Blog Post | 03.04.26
Let’s Talk FCA: Gender-Affirming Care and Anti-DEI Executive Orders
Podcast | 03.02.26
Let’s Talk FCA: Gender-Affirming Care and Anti-DEI Executive Orders




